Author:
Fekete Stefanie,Wewetzer Christoph,Mehler-Wex Claudia,Holtkamp Kristian,Burger Rainer,Reichert Susanne,Taurines Regina,Romanos Marcel,Gerlach Manfred,Egberts Karin
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology
Reference38 articles.
1. Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label study;Dittmann;J Child Adolesc Psychopharmacol.,2008
2. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder;Frazier;J Child Adolesc Psychopharmacol.,2001
3. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial;Kryzhanovskaya;J Am Acad Child Adolesc Psychiatry.,2009
4. Olanzapine plasma concentrations and clinical response in acutely III schizophrenic patients;Perry;J Clin Psychopharmacol.,1997
5. A double-blind placebo-controlled study of olanzapine in childhood/adolescent pervasive development disorder;Hollander;J Child Adolesc Psychopharmacol.,2006
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献